(Allergan plc)

	AGN latest price $211.2647 (3.31%) ($202.0184 - $211.9017) on Tue. Jan. 31, 2017.
	Trend Analysis and Forecast
Average Daily Percentage Swing	2.11% (three month average)
RSI	43
Latest Price	$211.2647(3.31%)
Stocks Behave Similarly	Similar Stock List
Daily Trend	AGN advances 0.5% a day on average for past five trading days.
Weekly Trend	AGN declines -0.7% a week on average for past two weeks.
Market Behavior	Normal for large cap. Broad based rally for small cap.
Correlated ETFs	Broad market will support AGN advance at 0% a week (0% probability)   IBB(50%)    XLV(49%)    XBI(44%)    ARKG(43%)    IVW(43%)
Factors Impacting AGN price	AGN will decline at least -1.055% in a week (0% probabilities).   VIXM(-29%)    TLT(-16%)    UUP(-15%)    SHY(-3%)    IPO(-3%)
Explanation	The rally is not sustainable and not supported by the broad market.
Relative Volatility	(options are extremely cheap)
Market Trend Strength	-1.055% (StdDev 2.11%)
Hourly BBV	0 ()
Intraday Trend	4.3%

5 Day Moving Average	$206.22(2.45%)
10 Day Moving Average	$206.7(2.21%)
20 Day Moving Average	$208.28(1.43%)
To recent high	-1.1%
To recent low	16.1%
Market Cap	$69.654b

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.

getNextHourMoveProbability failed